Is homozygous a-thalassaemia a lethal condition in the 1990s?

Acta Paediatrica, International Journal of Paediatrics

Volumn 87, Issue 11, 1998, Pages 1197-1199

  Ng, P C ^a,b   Fok, T F ^a   Lee, C H ^a   Cheung, K L ^a   Li, C K ^a   So, K W ^a   Wong, W ^a   Yuen, P M P ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b Department of Paediatrics   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN F; LUNG SURFACTANT;

ALPHA THALASSEMIA; ARTICLE; ARTIFICIAL VENTILATION; BLOOD TRANSFUSION; CASE REPORT; FEMALE; FETUS HYDROPS; HEMOGLOBINOPATHY; HOMOZYGOSITY; HUMAN; LETHALITY; MALE; NEWBORN; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME;

FATAL OUTCOME; FEMALE; HUMANS; HYDROPS FETALIS; INFANT, NEWBORN; MALE;

EID: 0031765570     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1651-2227.1998.tb00931.x     Document Type: Article

References (17)

1. Thumasalhit B, Nondasuta A, Silpisomkosol S, Lousuebsakul B, Unchalipongse P, Mangkornkanok M. Hydrops fetalis associated with Bart's hemoglobin in northern Thailand. Trop Pediatr 1968; 73: 132-8
2. Wong HB. Further studies in Bart's hydrops fetalis in Singapore. J Singapore PaediatrSoc 1970; 12: 79-84
3. Machin GA, Popkin JS, Styles S. Termination of pregnancy during the third trimester. N Engl J Med 1984; 311: 264-5
4. Beaudry MA, Ferguson DJ, Pearse K, Yanofsky RA, Rubin EM, Kan YW. Survival of a hydropic infant with homozygous a-thalassemia-1. J Pediatr 1986; 108: 713-6
5. Bianchi DW, Beyer EC, Stark AR, Saffan D, Sachs BP, Wolfe L. Normal long-term survival with a-thalassemia. J Pediatr 1986; 108: 716-8
6. Lam TK, Chan V, Fok TF, Li CK, Feng CS. Long-term survival of a baby with homozygous alpha-thalassemia-1. Acta Haematol 1992; 88: 198-200
7. Carr S, Rubin L, Dixon D, Star J, Dailey J. Intrauterine therapy for homozygous a-thalassemia. Obstet Gynccol 1995; 85: 876-9
8. Ghosh A, Tang MH, Lam YH, Fung E, Chan V. Ultrasound measurement of placenta! thickness to detect pregnancies affected by homozygous alpha-thalassaemia-1. Lancet 1994; 344: 988-9
9. Ko TM, Tseng LH, Hsu PM, Hwa HL, Lee TY, Chuong SM. Ultrasonographic scanning of placental thickness and the prenatal diagnosis of homozygous alpha-thalassaemia 1 in the second trimester. PrenatDiagn 1995; 15:7-10
10. Halliday HL. Synthetic or natural surfactants. Acta Paediatr 1997; 86: 233-7
11. Crowley PA. Antenatal corticosteroid therapy: a meta-analysis of the randomized trials 1972 to 1994. Am J Obstet Gynecol 1995; 173: 322-34
12. Ng PC. The effectiveness and side effects of dexamethasone in preterm infants with bronchopulmonary dysplasia. Arch Dis Child 1993; 68: 330-6
13. Weiner CP, Williamson RA, Wenstrom KD, Sipes SL, Widness JA, Grant SS, Estle L. Management of fetal hemolytic disease by cordocentesis. II. Outcome of treatment. Am J Obstet Gynecol 1991; 165: 1302-7
14. Perry KG Jr, Hess LW, Roberts WE, Albert JR, Floyd RC, McCaul JF, et al. Cordocentesis (funipuncture) by maternal-fetal fellows: the learning curve. Fetal Diagn Ther 1991; 6: 87-92
15. Apperley JF. Bone marrow transplant for the haemoglobinopathies: past, present and future. Baillieres Clin Haematol 1993; 6: 299-325
16. Ng PC, FokTF, Nelson HAS. Neonatology in the "Pearl of the East". J Paediatr Child Health 1996; 32: 362-7
17. Westgren M, Ringden O, Eik-Nes S, et al. Lack of evidence of permanent engraftment after in utero fetal stem cell transplantation in congenital hemoglobinopathies. Transplantation 1996; 61: 1176-9